Serum S100B levels in patients with neural tube defects

Clin Chim Acta. 2006 Feb;364(1-2):275-8. doi: 10.1016/j.cca.2005.07.028. Epub 2005 Sep 6.

Abstract

Background: We investigated the levels of S100B protein in the serum of patients with neural tube defects (NTD), and the ontogenetic variation on this group of patients.

Methods: Samples from 24 control individuals and 25 patients with NTD were studied. S100B protein levels were determined using LIA-mat Sangtec kit.

Results: We observed no difference between the levels of S100B in NTD patients (median 0.860 microg/l) and control individuals (median 0.580 microg/l). When groups were classified according to age, decreased levels were observed in subjects > or = 4 y compared to the younger ones, on the control group; no significant difference was observed when the same comparison is performed on the group of patients with NTD.

Conclusions: This study indicates that the serum concentration of S100B in patients with NTD is similar to that of normal individuals; however, patients with NTD do not show the negative correlation with age which was observed on normal individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Humans
  • Immunoassay / methods
  • Infant
  • Nerve Growth Factors / blood*
  • Neural Tube Defects / blood*
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins / blood*

Substances

  • Nerve Growth Factors
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins
  • S100B protein, human